Preliminary studies on the effects of orally-administered transforming growth factor-beta on protozoan diseases in mice

Japanese Journal of Veterinary Research

Volumn 57, Issue 2, 2009, Pages 101-108

  Namangala, Boniface ^a,c   Inoue, Noboru ^a   Sugimoto, Chihiro ^b  

^a OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c UNIVERSITY OF ZAMBIA   (Zambia)

Author keywords

Low dose; Mice; Orally delivered TGF l; Protection; Protozoan parasites

Indexed keywords

ANTIINFLAMMATORY AGENT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BABESIA; BABESIOSIS; BAGG ALBINO MOUSE; FEMALE; MALARIA; MOUSE; ORAL DRUG ADMINISTRATION; PARASITOSIS; PLASMODIUM BERGHEI; PROTOZOAL INFECTION; SURVIVAL RATE; TOXOPLASMA; TOXOPLASMOSIS;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BABESIA; BABESIOSIS; FEMALE; MALARIA; MICE; MICE, INBRED BALB C; PARASITIC DISEASES; PLASMODIUM BERGHEI; PROTOZOAN INFECTIONS; SURVIVAL RATE; TOXOPLASMA; TOXOPLASMOSIS; TRANSFORMING GROWTH FACTOR BETA;

MURINAE; MUS; PROTOZOA;

EID: 70350376734     PISSN: 00471917     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bellone, G., Aste-Amezaga, M., Trinchieri, G. and Rodeck, U. 1995. Regulation of NK cell functions by TGF-βl. J. Immunol., 155: 1066-1073.
2. Cummins, J. M., Krakowka, G. S. and Thompson, C. G. 2005. Systemic effects of interferons after oral administration in animals and humans. Am. J. Vet. Res., 66: 164-176
3. de Kossodo, S. and Grau, G. E. 1993. Profiles of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol., 151: 4811-4820.
4. Ishizaka, S., Kimoto, M., Kanda, S. and Saito, S. 1998. Augmentation of natural killer cell activity in mice by oral administration of transforming growth factor-p. Immunology, 95: 460-465
5. Kulmatycki, K. M. and Jamali, F. 2001. Therapeutic relevance of altered cytokine expression. Cytokine, 14: 1-10.
6. Namangala, B., Sugimoto, C. and Inoue, N. 2007. Effects of exogenous transforming growth factor b on Trypanosoma congolense infection in mice. Infect. Immun., 75: 1878-1885
7. Ogunremi, O. and Tabel, H. 1995. Genetics of resistance to Trypanosoma congolense in inbred mice: efficiency of apparent clearance of parasites correlates with long-term survival. J. ParasitoL, 81: 876-881
8. Omer, F.M., de Souza, J. B. and Riley, E. M. 2003. Differential induction of TGF-βregulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections. J. Immunol, 171: 5430-5436
9. Omer, F. M. and Riley, E. M. 1998. TGF-β production is inversely correlated with severity of murine malaria infection. J. Exp. Med., 188: 39-48.
10. Omer, F. M., Kurtzals, J. A. L. and Riley, E. M. 2000. Maintaining the immunological balance in parasitic infections: a role for TGF-β?. Parasitol. Today, 16: 18-23.
11. Luckhart, S., Lieber, M. J., Singh, N., Zamora, R. and Vodovotz, Y. 2007. Low levels of mammalian TGF-β 1 are protective against malaria parasite infection, a paradox clarified in the mosquito host malaria and trypanosomiasis. Exp. Parasitol, 118: 290-296
12. Schmieg, J., Yang, G., Franck, R. W. and Tsuji, M. 2003. Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide. J. Exp. Med., 198: 1631-1641
13. Smeltz, R. B., Chen, J. and Shevach, E. M. 2005. TGF-β 1 enhances the interferon-γ-dependent, interleukin-12-independent pathway of helper 1 cell differentiation. Immunology, 114: 484-492
14. Spaccapelo, R., Romani, L., Tonnetti, L., Cenci, E., Mencacci, A., Del Sero, G., Tognellini, R., Reed, S.C., Puccetti, P. and Bistoni, F. 1995. TGF-pi is important in determining the in vivo patterns of susceptibility or resistance in mice infected with Candida albicans. J. Immunol., 155: 1349-1360
15. Tovey, M.G. and Maury, C. 1999. Oromucosal interferon therapy: marked antiviral and antitumor activity. J. Interferon Cytokine Res., 19: 145-155. (Pubitemid 29109631)
16. Tsutsui, N. and Kamiyama, T. 1999. TGF-β- induced failure of resistance to infection with blood-stage Plasmodium chabaudi in mice. Infect. Immun., 67: 2306-2311
17. Wahl, S.M. 1994. Transforming growth factor-β: the good, the bad and the ugly. J. Exp. Med., 180: 1587-1590.
18. Wahl, S.M., McCartney-Francis, N. and Mergenhagen, S. E. 1989. Inflammatory and immunomodulatory roles of TGF-β. Immunol. Today, 10: 258-261.